• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·UK·Healthcare·ROIV
Held by 3 Gurus
Share

Roivant Sciences Ltd. Stocks

$ 34.21Last Updated 08.10.2026

Issuer Rating

3/7
Performance

Modest

Risk

Moderate

Recommendation

Sell

Market Cap

$ 25.35B

In Guru Portfolios

David Einhorn

Portfolio Weight (%)

2.0%

Change

+0.08%

Fund

Greenlight Capital

Steven Cohen

Portfolio Weight (%)

0.2%

Change

+0.14%

Fund

Point72 Asset Management, L.P.

Kenneth Griffin

Portfolio Weight (%)

0.0%

Change

+0.01%

Fund

CITADEL ADVISORS LLC

Manager
Fund
Portfolio Weight (%)
Change
David EinhornGreenlight Capital2.0%+0.08%
Steven CohenPoint72 Asset Management, L.P.0.2%+0.14%
Kenneth GriffinCITADEL ADVISORS LLC0.0%+0.01%

Trending

09.10.2026 13:23

What makes Physical Intelligence—the company Bezos has invested in—so interesting?

09.10.2026 13:07

Three of Freedom's subsidiaries have asked AIX to approve a bond program of up to $1 billion

09.10.2026 12:19

The Uzbek fintech startup Uzum may enter the international debt market

09.10.2026 12:04

The wave of IPO cancellations continues: one of Australia's largest IPOs has fallen through

09.10.2026 11:55

Analysts predict a 40% rise in Halyk Bank's stock price and the highest dividends in the region

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026